- Title
- Re-treatment with radium-223: An international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases
- Creators
- A. Oliver Sartor - Tulane Cancer Center, New Orleans, LADaniel Heinrich - Akershus University HospitalNeil Mariados - Associated Medical Professionals of New York, PLLC, Syracuse, NYMaría José Méndez-Vidal - Hospital Universitario Reina SofíaDaniel Keizman - Meir Medical CenterCamilla Thellenberg-Karlsson - University Hospital of UmeåAvivit Peer - Rambam Health Care CampusGiuseppe Procopio - Fondazione IRCCS Istituto Nazionale dei TumoriStephen Jay Frank - Hadassah Medical CenterKalevi Pulkkanen - Kuopio University HospitalEli Rosenbaum - Rabin Medical CenterStefano Severi - Istituti di Ricovero e Cura a Carattere ScientificoJose Manuel Trigo Perez - Hospital Universitario Virgen de la Victoria, Málaga, SpainPaul Schwarzenberger - Bayer (United States)Rui Li - Bayer (United States)Luke T. Nordquist - Urology Cancer Center and GU Research Network
- Publication Details
- Journal of clinical oncology, Vol.34(15_suppl), pp.5074-5074
- Identifiers
- 991006262541002656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
Re-treatment with radium-223: An international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases
Journal of clinical oncology, Vol.34(15_suppl), pp.5074-5074
05/20/2016
Metrics
1 Record Views